TearLab Corp  

(Public, NASDAQ:TEAR)   Watch this stock  
Find more results for TEAR
0.756
+0.008 (1.11%)
May 3 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 0.74 - 0.80
52 week 0.60 - 3.03
Open 0.75
Vol / Avg. 33,100.00/96,025.00
Mkt cap 24.80M
P/E     -
Div/yield     -
EPS -0.99
Shares 34.21M
Beta 3.06
Inst. own 42%
May 4, 2016
Q1 2016 TearLab Corp Earnings Call - 4:30PM EDT - Add to calendar
May 4, 2016
Q1 2016 TearLab Corp Earnings Release - 4:00PM EDT - Add to calendar
Mar 14, 2016
TearLab Corp at ROTH Conference
Mar 8, 2016
Q4 2015 TearLab Corp Earnings Call
Mar 8, 2016
Q4 2015 TearLab Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '15) 2015
Net profit margin -131.42% -132.09%
Operating margin -120.63% -125.25%
EBITD margin - -105.43%
Return on average assets -131.18% -111.92%
Return on average equity - -329.91%
Employees 118 -
CDP Score - -

Address

Suite 200, 7360 Carroll Rd
SAN DIEGO, CA 92121
United States - Map
+1-858-4556006 (Phone)
+1-858-8120540 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

TearLab Corporation is an in-vitro diagnostic company. The Company has commercialized a tear testing platform, the TearLab Osmolarity System, which enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. The Company, through its subsidiary TearLab Research, Inc., develops technologies to enable eye care practitioners to test a range of biomarkers (chemistries, metabolites, genes and proteins) at the point-of-care. Its product, the TearLab Osmolarity System, enables the measurement of tear osmolarity in the doctor's office. The TearLab Osmolarity System consists of approximately three components: the TearLab disposable, the TearLab Pen, and the TearLab Reader. The TearLab disposable is a single-use microfluidic microchip. The TearLab Pen is a hand-held device that interfaces with the TearLab disposable. The TearLab Reader is a small desktop unit that allows for the docking of the TearLab Pen.

Officers and directors

Elias Vamvakas Chairman of the Board
Age: 57
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Joseph Jensen President, Chief Executive Officer, Chief Operating Officer, Director
Age: 43
Bio & Compensation  - Reuters
Wes Brazell Chief Financial Officer
Age: 49
Bio & Compensation  - Reuters
Raymond Kong Vice President - Sales
Bio & Compensation  - Reuters
Venkiteshwar Manoj Vice President of Medical Affairs
Age: 37
Bio & Compensation  - Reuters
Paul Smith Vice President - International Markets
Age: 37
Bio & Compensation  - Reuters
Duane Morrison Vice President - Business Development
Age: 51
Bio & Compensation  - Reuters
Anthony E. Altig Independent Director
Age: 59
Bio & Compensation  - Reuters
Thomas N. Davidson Jr. Independent Director
Age: 55
Bio & Compensation  - Reuters
Adrienne L. Graves Ph.D. Independent Director
Age: 61
Bio & Compensation  - Reuters